Inspira Technologies OXY B.H.N. Ltd. announced that it has submitted a patent application to the Israeli Patent Office for a supportive device to be utilized with its ART device. The supportive device is aimed to allow for a safe treatment and mobilization of cannulated patients. This is expected to provide the medical staff more flexibility in implementing treatment procedures as well as to enable the safe transfer of patients within and between hospitals and medical centers. The device can also be potentially utilized in the treatment of thousands of patients being treated each year by Extracorporeal Membrane Oxygenation (ECMO) as well as additional treatments requiring patient cannulation, including treatments for COVID-19, chronic obstructive pulmonary disease (COPD), pneumonia and acute respiratory distress syndrome (ARDS).